MediPharm Labs (TSE:LABS) Sets New 12-Month Low – Should You Sell?

Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low during trading on Monday. The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 10,591 shares changing hands. The stock had previously closed at C$0.07.

MediPharm Labs Stock Down 7.7%

The firm’s 50-day moving average price is C$0.07 and its 200 day moving average price is C$0.07. The company has a current ratio of 2.66, a quick ratio of 3.10 and a debt-to-equity ratio of 0.90. The company has a market capitalization of C$25.63 million, a price-to-earnings ratio of -6.00 and a beta of -0.60.

MediPharm Labs Company Profile

(Get Free Report)

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.

See Also

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.